Clinical Care

  • The only National Cancer Institute center serving California’s Central Valley and inland Northern California, a region of 6 million people
  • Cares for more than 10,000 adults and children each year
  • More than 400 adult and pediatric cancer clinical trials under way
  • Affiliate cancer centers through the Cancer Care Network in Yuba City, Truckee and Merced, Ridgecrest and South Lake Tahoe offering patients state-of-the-art cancer care close to home
  • Highly trained oncology-certified nurses
  • The only National Marrow Donor Program Transplant Center in the region
  • Provides a full range of prevention, diagnosis, treatment, survivorship and hospice/palliative care programs for children and adults

Research

  • $63 million in National Institutes of Health/CHI funding with nearly 300 scientists at work on nearly 300 projects, distributed among 42 UC Davis departments and eight schools, including the School of Veterinary Medicine
  • The first major cancer center to forge a formal research partnership with a national laboratory, Lawrence Livermore National Laboratory
  • Collaboration with JAX-West Laboratories to develop better research models for new therapies
  • SCOPE: a city-wide phase I clinical research program offering novel therapies to patients throughout the region
  • Leaders in translational research, with achievements in:
    • Combinatorial chemistry and novel nanotherapeutics for drug delivery and imaging
    • Anti-androgen and other novel therapeutic approaches for advanced prostate cancer
    • Basic science in DNA damage and repair and signal transduction
    • Glycomics in cancer diagnosis, prognosis and imaging
    • Biomedical technologies including EXPLORER, the world’s first total-body PET scanner
    • Comparative oncology studies using pet dogs with spontaneous tumors to test novel therapies for human patients
  • Robust research, education and outreach to reduce vaccine-preventable cancers and cancers disproportionately affecting racial/ethnic minorities.